Home
Johan G Brun's picture

Johan G Brun

Professor
  • E-mailJohan.Brun@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2019. Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary sjogren's syndrome. Frontiers in Immunology. 1-18.
  • 2019. Juvenile Sjögren’s syndrome: clinical characteristics with focus on salivary gland ultrasonography. Arthritis care & research. 78-87.
  • 2019. Assessment of major salivary gland ultrasonography in Sjögren’s syndrome. A comparison between bedside and post-examination evaluations. Clinical and Experimental Rheumatology. S153-S158.
  • 2018. T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 1-15.
  • 2018. Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PLOS ONE. 1-18.
  • 2018. Marine ω-3, vitamin D levels, disease outcome and periodontal status in rheumatoid arthritis outpatients. Nutrition - The International Journal of Applied and Basic Nutritional Sciences. 116-124.
  • 2018. Aberrant cell signalling in PBMCs upon IFN-? stimulation in primary Sjogren's syndrome patients associates with type I interferon signature. European Journal of Immunology. 1217-1227.
  • 2017. Patients with primary Sjögren's syndrome have alterations in absolute quantities of specific peripheral leucocyte populations. Scandinavian Journal of Immunology. 491-502.
  • 2017. Long-term follow-up in primary Sjogren's syndrome reveals differences in clinical presentation between female and male patients. Biology of Sex Differences. 1-9.
  • 2017. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren Project Consortium. Annals of the Rheumatic Diseases. 1042-1050.
  • 2017. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics. 1-29.
  • 2016. Sjögren's syndrome patients with ectopic germinal centers present with a distinct salivary proteome. Rheumatology. 1127-1137.
  • 2016. Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome. Clinical and Experimental Rheumatology. 1006-1012.
  • 2016. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Annals of the Rheumatic Diseases. 382-389.
  • 2016. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab. Scandinavian Journal of Rheumatology. 274-281.
  • 2015. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and Patient indexes (ESSPRI). Annals of the Rheumatic Diseases. 859-866.
  • 2015. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 582-596.
  • 2015. TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines. Scandinavian Journal of Immunology. 523-531.
  • 2015. Serum markers in rheumatoid arthritis: A longitudinal study of patients undergoing infliximab treatment. International Journal of Rheumatology. 1-9.
  • 2015. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome. Arthritis & Rheumatology. 1084-1095.
  • 2015. Expression of toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome. PLOS ONE. 13 pages.
  • 2015. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome. Clinical and Experimental Rheumatology. 56-62.
  • 2014. The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab. BMC Musculoskeletal Disorders. 5 pages.
  • 2014. Genetic associations to germinal centre formation in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1253-1258.
  • 2014. Carbamylation of immunoglobulin abrogates activation of the classical complement pathway. European Journal of Immunology. 3403-3412.
  • 2014. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome. Arthritis Research & Therapy.
  • 2014. A possible genetic association with chronic fatigue in primary Sjögren’s syndrome: a candidate gene study. Rheumatology International. 191-197.
  • 2013. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 1284-1292.
  • 2013. Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care and Research. 816-821.
  • 2013. No association of primary Sjögren's syndrome with Fcγ receptor gene variants. Genes and Immunity. 234-237.
  • 2013. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome. Arthritis Research & Therapy. 12 pages.
  • 2013. Association of genes in the NF-kappa B pathway with antibody-positive Primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 447-454.
  • 2012. The risk of Non-Hodgkin Lymphoma in Primary Sjögren's Syndrome, a population-based study. Arthritis Care and Research.
  • 2012. Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions. Scandinavian Journal of Clinical and Laboratory Investigation. 129-136.
  • 2012. Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study. Journal of Rheumatology. 2008-2011.
  • 2012. Autoantigen-specific memory B cells in primary Sjögren's syndrome. Scandinavian Journal of Immunology. 61-68.
  • 2012. Association between genetic variants in the tumour necrosis factor/lymphotoxin alpha/lymphotoxin beta locus and primary Sjogren's syndrome in Scandinavian samples. Annals of the Rheumatic Diseases. 981-988.
  • 2011. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 221-224.
  • 2011. Potential association of muscarinic receptor 3 gene variants with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1327-1329.
  • 2011. Phenotypic diversity of peripheral blood plasma cells in primary Sjögren’s Syndrome. Scandinavian Journal of Immunology. 18-28.
  • 2011. Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome. International Immunopharmacology. 2125-2129.
  • 2011. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 968-972.
  • 2011. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes and Immunity. 100-109.
  • 2011. A five-year prospective study of fatigue in primary Sjögren’s syndrome. Arthritis Research & Therapy.
  • 2010. MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity. Neuroradiology. 215-223.
  • 2010. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1235-1238.
  • 2009. Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome. Rheumatology. 1102-1106.
  • 2009. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes and Immunity. 68-76.
  • 2008. Sjögrens syndrom. Norsk Epidemiologi. 67-72.
  • 2008. Impact of lean mass and fat mass on bone mineral density: The Hordaland Health Study. Maturitas. 191-200.
  • 2008. Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Annals of the Rheumatic Diseases. 949-954.
  • 2008. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scandinavian Journal of Rheumatology. 30-34.
  • 2007. Sjögren's syndrome - A plethora of clinical and immunological phenotypes with a complex genetic background. Annals of the New York Academy of Sciences. 433-447.
  • 2007. Serological Implications of Germinal Center-like structures in Primary Sjögren’s Syndrome. Journal of Rheumatology. 2044-2049.
  • 2007. S100 proteins calprotectin and S100A12 are related to' radiographic changes rather than disease activity in psoriatic arthritis with low disease activity. Journal of Rheumatology. 2089-2092.
  • 2007. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology. 417-425.
  • 2007. Anti-tumor necrosis factor-alpha therapy in the ordinary clinical setting: Three-year effectiveness in patients with rheumatoid arthritis. Joint Bone Spine. 606-611.
  • 2007. 257 ankle arthroplasties performed in Norway between 1994 and 2005. Acta Orthopaedica. 575-583.
  • 2006. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clinical and Experimental Rheumatology. 57-65.
  • 2006. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of bacterial DNAs. Clinical and Experimental Rheumatology. 656-663.
  • 2006. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. Journal of Rheumatology. 307-310.
  • 2006. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids in Health and Disease.
  • 2006. Polymyalgia rheumatica in primary Sjogren's syndrome. Rheumatology International. 401-403.
  • 2006. Lipids in health and disease. Lipids in Health and Disease.
  • 2006. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Archives of Neurology. 1410-1413.
  • 2005. The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: A pilot study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 433-440.
  • 2005. Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity. Oral Diseases. 27-34.
  • 2005. Prevalence, Disease Manifestations and Treatment of Psoriatic Arthritis in Western Norway (County of Hordaland). Journal of Rheumatology. 1918-1922.
  • 2005. Oral bacterial DNAs in synovial fluids of arthritis patients. Microbial Ecology in Health and Disease. 2-8.
  • 2004. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scandinavian Journal of Gastroenterology. 1088-1094.
  • 2004. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF. Journal of Clinical Immunology. 600-611.
  • 2004. Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporosis International. 525-534.
  • 2004. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scandinavian Journal of Immunology. 592-599.
  • 2003. Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Laboratory Investigation. 1839-1848.
  • 2003. Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Laboratory Investigation. 1839-1848.
  • 2003. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clinical and Laboratory Immunology. 1043-1050.
  • 2003. A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Care &Research. 187-192.
  • 2002. Sjögren's syndrome in an out-patient clinic: Classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Sveits). 301-304.
  • 2002. Leucocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scandinavian Journal of Rheumatology. 351-354.
  • 2002. Immunoglobulin G Fc-receptor (FcGammaR) IIA, IIIA and IIIB polymorphisms related to disease severity in rheumatoid arthritis. Journal of Rheumatology. 1135-1140.
  • 2002. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids. 935-940.
  • 2002. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids. 935-940.
  • 1999. Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus. 269-273.
  • 1999. Immunoglobulin G, Fc-receptor IIA and IIB plymorphisms related to disease severity in rheumatoid arthritis. Arthritis and Rheumatism. 1045-Abstract.
  • 1999. Complement activation in patients with systemic lupus erythematosus without nephritis. Rheumatology. 933-940.
  • 1996. Pristane-Induced Arthritis in Rats. A New Model for Rheumatoid Arthritis with a Chronic Disease Course Influenced by Both Major Histocompatibility Complex and Non-Major Histocompatibility Complex Genes. American Journal of Pathology. 1675-1683.
  • 1994. Use of a sicca symptoms questionnaire for the identification of patients with Sj@øgren's syndrome in a heterogeneous hospital population with various rheumatic diseases. Clinical and Experimental Rheumatology. 649-652.
  • 1994. Sj@øgren's syndrome in inflammatory rheumatic diseases: Analysis of the leukocyte protein calprotectin in plasma and saliva. Scandinavian Journal of Rheumatology. 114-118.
  • 1994. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. Journal of Rheumatology. 733-738.
  • 1994. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. Journal of Rheumatology. 733-738.
  • 1994. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scandinavian Journal of Immunology. 675-680.
  • 1994. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scandinavian Journal of Immunology. 675-680.
  • 1993. Cancer in association with polymyalgia rheumatica and temporal arteritis. Journal of Rheumatology. 135-139.
  • 1993. Cancer in association with polymyalgia rheumatica and temporal arteritis. Journal of Rheumatology. 1335-1339.
  • 1993. Calprotectin in patients with systemic lupus erythematosus: Relation to clinical and laboratory parameters of disease activity. Lupus. 47-50.
  • 1993. Calprotectin in patients with systemec lupus erythematosus: Relation to clinical and laboratory parameters of disease activity. Lupus. 47-50.
  • 1992. Morning stiffness and nighttime pain in ankylosing spondylitis. A comparison between entericcoated and plain naproxen tablets. European Journal of Rheumatology and Inflammation. 37-42.
  • 1992. Calprotectin in patients with rheumatoid arthritis: Relation to clinical and laboratory variables of disease activity. Journal of Rheumatology. 859-862.
Report
  • 2010. 33 Scandinavian Congress of Rheumatology Abstract Supplement. 124. 124. .
Academic lecture
  • 2019. Assessment of major salivary gland ultrasonography in Sjögren’s syndrome.
  • 2005. Effekt av selolje vs soyaolje på leddsmerter ved inflammatorisk tarmsykdom.
  • 2004. Seal oil compared to soy oil in patients with inflammatory bowel disease.
  • 2004. Germinal Centers in Primary Sjögren�s Syndrome Indicate a Certain Clinical Immunological Phenotype.
  • 2003. Seal oil compared to soy oil in patients with inflammatory bowel disease.
  • 2001. Sjögren's syndrome in an out-patient clinic: Classification of patients according to the preliminary European Criteria and the proposed modified European criteria.
  • 2000. Leucocyte protein calprotectin and five-year outcome in rheumatoid arthritis.
  • 2000. Leucocyte protein calprotectin and five-year outcome in rheumatoid arthritis.
  • 2000. Immunoglobulin G Fc-receptor (FcgR) IIA and IIIB polymorphisms related to disease severity in rheumatoid arthritis.
  • 1998. Seasonal variations in activity of Systemic Lupus Erythematosus (SLE) in a subarctic region.
  • 1998. A longitudinal study of plasma calprotectin as a marker of disease activity in patients with SLE.
  • 1994. Sj@øgrens syndrome - en tverrfaglig diagnose.
  • 1994. Serum calprotectin (L1): A new marker of disease activity in systemic lupus erythematosus (SLE).
  • 1994. Immunohistochemical analyses of calprotectin synthesizing cells in Sj@øgren's syndrome.
  • 1994. Calprotectin levels in oral fluids with reference to Sj@øgren's syndrome.
  • 1994. Breast feeding, other reproductive factors, and rheumatoid arthritis. A prospective study.
  • 1993. Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • 1993. Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • 1993. Plasma levels of the leukocyte protein calprotectin (L1): A sensitive marker of arthritis in inflammatory rheumatic diseases.
  • 1993. Immunostimulatory effect of calprotectin (L1) on B lymphocytes.
Editorial
  • 2010. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 1731-1732.
Reader opinion piece
  • 2014. Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjögren's syndrome. Scandinavian Journal of Rheumatology. 76-78.
Short communication
  • 2012. En kvinne i 30-arene med smerter i fingre og tær. Tidsskrift for Den norske legeforening. 2401-2403.
  • 2010. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1731-1732.
Masters thesis
  • 2007. Vannlatingsplager hos kvinner med Sjögren's syndrom.
Popular scientific article
  • 2013. Sjögrens syndrom -en oppdatering. Revmatologi BestPractice. 18-21.
Feature article
  • 1998. Calprotectin in inflammatory rheumatic disease - summary of thesis. Scandinavian Journal of Rheumatology. 87-87.
Doctoral dissertation
  • 2011. Epidemiological, clinical, and immunogenetic aspects of primary Sjögren's syndrome.
  • 2007. Epidemiological studies of osteoporosis in Hordaland. Issues related to body composition and B-vitamins.
  • 2007. Calprotection (S100A8/A9) and S100A12 in inflammatory arthritis : clinical and epidemiological studies of rheumatoid and psoriatic arthritis.
  • 2005. The role of B-cells in the pathogenesis of systemic autoimmune diseases - impaired process involving B-cell activation factor and apoptosis.
  • 2005. Oral implications of rheumatoid arthritis - a clinical and immunological approach.
  • 1996. Calprotectin in inflammatory rheumatic diseases. Clinical and experimental studies. -.
Academic chapter/article/Conference paper
  • 2007. Immunologi og revmatologi. 19 pages.
  • 1994. Calprotectin in chronically inflamed salivary glands and saliva. 3 pages.
Other
  • 2005. Serum CCL2, CCL11, and EGF as biomarkers in the spondylarthropaties. 11-14.
Abstract
  • 2018. Ultrasonography of major salivary glands in juvenile Sjögren’s syndrome: an international multicentre study. Clinical and Experimental Rheumatology. S-248.
  • 2018. Salivary gland ultrasound in patients with Sjögren’s syndrome – A comparison between bed-side, video and still-image scoring. Clinical and Experimental Rheumatology. S-324.
  • 2018. Distinct and persistent cytokine profiles associated with histopathological features in primary Sjögren’s syndrome. Clinical and Experimental Rheumatology. S-295.
  • 2015. Epidemiology of GCA in Bergen (Western Norway) 1972-2012. Arthritis & Rheumatology.
  • 2013. Carbamylation of immunoglobulin abrogates the classical pathway of complement activation. Immunology. 76-76.
  • 2012. Validation of EULAR Primary Sjogren's Syndrome Disease Activity and Patient Indexes. Arthritis and Rheumatism. S1078-S1078.
  • 2012. Ultrasonography of Major Salivary Glands in Primary Sjogren's syndrome. Arthritis and Rheumatism. S925-S925.
  • 2012. No association of primary Sjögren's Syndrome with Fc gamma? Receptor gene variants. Scandinavian Journal of Immunology. 198-198.
  • 2010. Prevalence of primary Sjogren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 36-36.
  • 2010. Patients with Primary Sjogren's Syndrome have Significantly Reduced Amounts of Plasmacytoid and Type 2 Myeloid Dendritic Cells in Peripheral Blood. Scandinavian Journal of Immunology. 479-479.
  • 2010. Fc gamma receptor IIA, IIIA and IIIB single nucleotide polymorphisms and Fc gamma receptor IIIB copy number variation: No association with primary Sjögren's syndrome. Scandinavian Journal of Rheumatology. 36-36.
  • 2010. Association between Lymphotoxin Alpha Genetic Variants and Primary Sjögren`s Syndrome in Scandinavian Samples. Arthritis and Rheumatism. 788-789.
  • 2008. Use of bladder capacity and uroflowmetry to elucidate lower urinary tract symptoms (LUTS) in primary Sjögren’s Syndrome (PSS). Annals of the Rheumatic Diseases. 617-617.
  • 2008. Histopathology in Seropositive Focus Score Negative Primary Sjögren’s Syndrome. Annals of the Rheumatic Diseases. 470-470.
  • 2008. Association of Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with BLK. Clinical Immunology. S41-S41.
  • 2008. Association of BLK with Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) initially identified by whole genome DNA pooling. Arthritis and Rheumatism. S791-S791.
  • 2008. Additive effects of the major risk Alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Arthritis and Rheumatism. S430-S430.
  • 2007. S100 proteins calprotectin and S100A12 are related to radiological changes rather than disease activity in psoriatic arthritis. Annals of the Rheumatic Diseases. 98.
  • 2006. Serum levels of soluble E-cadherin as an indicator of chronic inflammatory disease. Scandinavian Journal of Rheumatology. 45-45.
  • 2006. Germinal centers in primary Sjogren's syndrome indicate a certain clinical immunological phenotype. Scandinavian Journal of Rheumatology. 21-22.
  • 2006. Exocrine function in Sjogren's syndrome: Natural course and prognostic factors. Annals of the Rheumatic Diseases.
  • 2006. Calprotectin and S100A12 correlate with disease activity in rheumatoid arthritis, and S100A12 is associated with concomitant cardiovascular disease. Scandinavian Journal of Rheumatology. 40-40.
  • 2006. Anti TNF-alpha treatment of patients with rheumatoid arthritis.Outcome in an ordinary clinical setting. Scandinavian Journal of Rheumatology. Supplement. 41-41.
  • 2004. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjogren's syndrome with a special 2 emphasis on BAFF. Arthritis and Rheumatism. S578-S578.
  • 2003. Seal oil compared to soy oil in patients with inflammatory bowel disease. Gastroenterology. 67-67.
Poster
  • 2017. Ultrasonography of major salivary glands in juvenile Sjögren's syndrome – preliminary findings in a multi-center study.
  • 2017. Subgingival Microbiome of Rheumatoid Arthritis Patients in Relation to Their Periodontal Health.
  • 2017. Minor Salivary Gland Histopathology, Major Salivary Gland Ultrasonography, and Secretory Function in Smoking Patients with Primary Sjögren’s Syndrome.
  • 2017. Major salivary gland ultrasonography bed-side and still image scoring – A pilot comparison in juvenile Sjögren’s syndrome.
  • 2017. Difference in clinical presentation between female and male patients with primary Sjögren’s syndrome at diagnosis and in long-term follow-up.
  • 2017. Comparison of paperpoint and curette sampling of subgingival microbiome composition as analyzed by 16S rRNA gene amplicon sequencing.
  • 2016. Vitamin D status and seafood intake in rheumatoid arthritis patients with and without periodontitis.
  • 2016. Ultrasonography of major salivary glands in juvenile Sjögren's syndrome - Preliminary findings in a multi-center study.
  • 2015. Automating evaluation of salivary gland ultrasound images in pSS patients using the scattered transform algorithm – A pilot study.
  • 2011. Association between tumor necrosis factor, lymphotoxin alpha and beta genetic variants and primary Sjögren`s syndrome in Scandinavian samples.
  • 2011. A five-year prospective study of fatigue in primary Sjögren’s syndrome. P79. The 11th International Symposium on Sjögren's Syndrome.
  • 2009. Prevalence of primary Sjögren's syndrome in two Norwegian counties.
  • 2009. Possible association of Sjögren’s Syndrome (SS) with THRB, the thyroid hormone receptor beta.
  • 2009. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjögren's syndrome.
  • 2009. Genetic association between methyl-CpG-binding protein 2 (MECP2) and primary Sjögren’s syndrome.
  • 2009. Genes associated with Systemic Lupus Erythematosus (SLE) that are shared with Sjögren’s Syndrome (SS).
  • 2009. Fc receptor IIA, IIIA and IIIB single nucleotide polymorphisms and Fc receptor IIIB copy number variation: No association with primary Sjögren’s syndrome.
  • 2009. Dendritic cells from patients with primary Sjögren's syndrome have slightly enhanced endocytic capacity.
  • 2009. Cytokine and autoantibody profiling in primary Sjögren's syndrome.
  • 2009. Candidate genes for Sjögren’s syndrome (SS) susceptibility can be identified by genome wide scans (GWAS) with pooled DNA.
  • 2009. Association of C8orf13-BLK and TNFSF4 Gene Variants with Primary Sjögren's Syndrome.
  • 2007. Serological Implications of Germinal Center-like structures in Primary Sjögren’s Syndrome.
  • 2005. Germinal centers in primary Sjögren’s syndrome indicate a certain clinical immunological phenotype.
  • 2005. Ectopic germinal center formation in salivary glands of patients with Sjögren’s syndrome – morphological and phenotypic identification.
  • 2004. Germinal Centers in Primary Sjögren�s Syndrome Indicate a Certain Clinical Immunological Phenotype.
  • 2002. Helicobacter Pylori seroreactivity and disease parameters in primary Sjögren's syndrome and rheumatoid arthritis.
  • 2001. Immunoglobulin G Fc-receptor (FcGammaR) IIIA polymorphisms related to disease severity in rheumatoid arthritis.
  • 2001. A prospective study of sicca symptoms in patients with rheumatoid arthritis.
  • 1999. Immunoglobulin G Fc-receptor (FC_gR) IIA and IIIB polymorphisms related to disease severity in rheumatoid arthritis.
Academic literature review
  • 2016. Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. 133-142.
  • 2012. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. 276-280.
  • 2010. Sjögren's Syndrome.
  • 2008. The complex role of vitamin D in autoimmune diseases. 261-269.

More information in national current research information system (CRIStin)